Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Quiet Power of Keywords.

Western journal of nursing research·2026
Same author

Implementation Science.

Western journal of nursing research·2026
Same author

Academic Help-Seeking Behavior in Nursing Students: A Scoping Review.

The Journal of nursing education·2026
Same author

Precision Health Needs Nursing Science.

Western journal of nursing research·2026
Same author

Understanding System-Level Experiences Impacting Black Americans' Adherence to Antihypertensive Medication.

Journal of racial and ethnic health disparities·2025
Same author

Screening for Adverse Childhood Experiences in Adolescents Using the Bright Futures Previsit Questionnaire.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners·2024
Same journal

Nurse staffing disparities in nursing homes: Effects of community distress level and COVID-19.

Nursing outlook·2026
Same journal

The PAMSS Model: Ethical decision-making on companion animal presence in nursing practice.

Nursing outlook·2026
Same journal

A 6-year latent profile analysis of teamwork climate, job satisfaction, and emotional exhaustion among healthcare workers at a Taiwanese medical center.

Nursing outlook·2026
Same journal

Redesigning ecosystems for all children to enhance health and well-being: An American Academy of Nursing consensus paper.

Nursing outlook·2026
Same journal

Understanding what motivates job choices among registered nurses: A discrete choice experiment study.

Nursing outlook·2026
Same journal

Corrigendum to "The effect of surgical nurses' phubbing levels on their care behaviors: A descriptive and correlational study" [Nursing Outlook 74/1 (2026) 102653].

Nursing outlook·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Using meta-analyses for comparative effectiveness research.

Vicki S Conn1, Todd M Ruppar, Lorraine J Phillips

  • 1Meta-Analysis Research Center, School of Nursing, University of Missouri, Columbia, MO 65211, USA. conn@missouri.edu

Nursing Outlook
|July 14, 2012
PubMed
Summary
This summary is machine-generated.

Meta-analysis enhances comparative effectiveness research by focusing on intervention effect magnitudes. This method reveals patterns in patient outcomes and intervention characteristics, informing patient-centered care strategies.

More Related Videos

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Related Experiment Videos

Last Updated: May 20, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Area of Science:

  • Health Services Research
  • Biostatistics

Background:

  • Comparative effectiveness research (CER) aims to identify optimal interventions for specific patient groups.
  • Meta-analysis is a key CER tool, emphasizing effect size over statistical significance.

Purpose of the Study:

  • To highlight the value of meta-analysis in CER.
  • To explain how meta-analysis reveals intervention effectiveness and patient-centered care insights.

Main Methods:

  • Calculating overall effects for clinical and patient-centered variables.
  • Conducting moderator analyses to examine how intervention characteristics influence effect sizes.
  • Linking intervention effectiveness to patient characteristics.

Main Results:

  • Meta-analysis quantifies intervention effects and identifies outcome patterns.
  • Moderator analyses uncover relationships between intervention features and effectiveness, often addressing questions beyond primary studies.
  • Effectiveness can be tailored to specific patient populations.

Conclusions:

  • Meta-analysis offers unique contributions to knowledge in comparative effectiveness research.
  • Findings from meta-analysis support evidence-based, patient-centered care.
  • Acknowledging methodological limitations in primary studies is crucial for accurate meta-analysis interpretation.